News release
From:
JAMA
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode
About The Study: The findings of this systematic review and meta-analysis suggest that single and repeated intravenous ketamine infusions are efficacious in reducing suicidal and depressive symptoms in patients with a major depressive episode in the acute phase, while longer-term outcomes are not well established.
Journal/
conference:
JAMA Psychiatry
Organisation/s:
University of Connecticut, USA, Konyang University, South Korea
Funder:
This work was supported by
the Intramural Research Program at the National
Institute of Mental Health, National Institutes of
Health. Dr Kaster was supported by the Canadian
Institutes of Health Research, the AFP Innovation
Fund, and PCORI. Dr Rhee was supported in part by
the National Institute on Aging (R21AG070666;
R21AG078972), National Institute of Mental Health
(R21MH117438), National Institute on Drug Abuse
(R21DA057540), and Institute for Collaboration
on Health, Intervention, and Policy, University
of Connecticut.
Role of the Funder/Sponsor: The funders had no
role in the design and conduct of the study;
collection, management, analysis, and
interpretation of the data; preparation, review,
or approval of the manuscript; or decision to
submit the manuscript for publication.